UPFRONT SURGERY AS FIRST-LINE TREATMENT IN PATHOLOGICAL N2 NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Bertolaccini, L. [1 ]
Prisciandaro, E. [1 ]
Sedda, G. [1 ]
Girelli, L. [1 ]
Ieo, L. Spaggiari [1 ]
机构：
[1] European Inst Oncol, Thorac Surg, Milan, Italy
来源：
CHEST | 2022年 / 161卷 / 06期
关键词：
lung cancer;
D O I：
10.1016/j.chest.2021.12.345
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：315A / 315A
页数：1
相关论文
共 50 条
  • [1] Upfront Surgery Versus Neoadjuvant Treatment Followed by Surgery in Pathologic N2 Non-Small Cell Lung Cancer
    Kim, S. K.
    Park, H. S.
    Cho, K. D.
    Cho, D. G.
    Park, Y. H.
    Yoo, J.
    Kim, S. H.
    Ko, J. M.
    Park, E. J.
    Heo, G. R.
    Kim, C. H.
    Shim, B. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S900 - S901
  • [2] First-line treatment for non-small cell lung cancer
    Pinn, Stephen
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (01) : 10 - 10
  • [3] Outcome of surgery for non-small cell lung cancer with pathological N2 disease
    Elsayed, Abdelrahman Elsayed
    Ahmed, Hesham Ahmed
    Limbachia, Devan Limbachia
    Hawari, Mohammad Hawari
    LUNG CANCER, 2021, 156 : S68 - S69
  • [4] Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer
    Zheng, Difan
    Ye, Ting
    Hu, Hong
    Zhang, Yawei
    Sun, Yihua
    Xiang, Jiaqing
    Chen, Haiquan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (04): : 1814 - +
  • [5] Pembrolizumab for the first-line treatment of non-small cell lung cancer
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1015 - 1021
  • [6] Pemetrexed in first-line treatment of non-small cell lung cancer
    Esteban, Emilio
    Casillas, Marta
    Cassinello, Alejo
    CANCER TREATMENT REVIEWS, 2009, 35 (04) : 364 - 373
  • [7] Recent Clinical Outcomes of Upfront Surgery Followed by Adjuvant Therapy for Resectable Pathological N2 Non-Small Cell Lung Cancer
    Yun, J. K.
    Chong, Y.
    Jeong, Y. H.
    Lee, H. P.
    Bok, J. S.
    Lee, G. D.
    Kim, H. R.
    Kim, Y.
    Kim, D. K.
    Park, S.
    Choi, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S410 - S411
  • [8] Editorial on "upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer"
    Lin, Hongsheng
    Qiao, Kun
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2192 - S2194
  • [9] The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer
    Thomas, Daniel C.
    Arnold, Brian N.
    Rosen, Joshua E.
    Salazar, Michelle C.
    Detterbeck, Frank C.
    Blasberg, Justin D.
    Boffa, Daniel J.
    Kim, Anthony W.
    WORLD JOURNAL OF SURGERY, 2018, 42 (01) : 161 - 171
  • [10] The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer
    Daniel C. Thomas
    Brian N. Arnold
    Joshua E. Rosen
    Michelle C. Salazar
    Frank C. Detterbeck
    Justin D. Blasberg
    Daniel J. Boffa
    Anthony W. Kim
    World Journal of Surgery, 2018, 42 : 161 - 171
12345